EP3749353
Nemólísúmab til meðhöndlunar á ofnæmishúðbólgu með miðlungs til alvarlegt fleiður
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.2.2019EP published:
30.7.2025EP application number:
19710488.8
EP translation filed:
17.10.2025Grant published:
15.11.2025EPO information:
European Patent Register
Max expiry date:
7.2.2039Expiry date:
7.2.2027Next due date:
28.2.2027
Title in English:
NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATIONLanguage of the patent:
English
Timeline
Today
8.2.2019EP application
30.7.2025EP Publication
17.10.2025Translation submitted
15.11.2025Registration published
7.2.2027Expires
Owner
Name:
Galderma Holding SAAddress:
Zählerweg 10, 6300 Zug, CH
Name:
Chugai Seiyaku Kabushiki KaishaAddress:
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, JP
Inventor
Name:
KERROUCHE, NabilAddress:
06650 Le Rouret, FR
Name:
HIROKAWA, KeikoAddress:
Tokyo, Tokyo 103-8324, JP
Name:
MIHARA, RyosukeAddress:
Tokyo, Tokyo 103-8324, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862628714 PDate:
9.2.2018Country:
US
Classification
Categories:
A61K 39/00, A61P 17/04, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 16.2.2026
Expires: 7.2.2027
Payer: G.H. Sigurgeirsson ehf.